See more : Ningbo Huaxiang Electronic Co., Ltd. (002048.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Aurora Cannabis Inc. (ACB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aurora Cannabis Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Ucommune International Ltd (UK) Income Statement Analysis – Financial Results
- Semapa – Sociedade de Investimento e Gestão, SGPS, S.A. (SEM.LS) Income Statement Analysis – Financial Results
- GMéxico Transportes, S.A.B. de C.V. (GMXTF) Income Statement Analysis – Financial Results
- BlackBerry Limited (BB) Income Statement Analysis – Financial Results
- Reading International, Inc. (RDIB) Income Statement Analysis – Financial Results
Aurora Cannabis Inc. (ACB)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.auroramj.com
About Aurora Cannabis Inc.
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 270.28M | 233.29M | 221.34M | 245.25M | 278.91M | 247.94M | 55.20M | 18.07M | 1.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.83K | 0.00 | 0.00 |
| Cost of Revenue | 138.82M | 297.65M | 200.11M | 266.81M | 312.45M | 88.12M | 11.68M | 2.01M | 763.00K | 304.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 131.46M | -64.36M | 21.23M | -21.56M | -33.54M | 159.82M | 43.52M | 16.06M | 676.27K | -304.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.83K | 0.00 | 0.00 |
| Gross Profit Ratio | 48.64% | -27.59% | 9.59% | -8.79% | -12.03% | 64.46% | 78.84% | 88.87% | 46.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 3.57M | 6.56M | 10.39M | 11.45M | 26.07M | 14.78M | 1.68M | 314.00K | 565.14K | 432.38K | 307.93K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 104.94M | 68.22M | 126.97M | 139.68M | 265.18M | 279.40M | 80.42M | 14.40M | 3.93M | 2.61M | 280.67K | 152.64K | 250.02K | 181.96K | 49.99K | 185.35K | 0.00 | 0.00 |
| Selling & Marketing | 51.94M | 51.97M | 62.03M | 55.20M | 91.27M | 99.29M | 29.45M | 10.27M | 1.71M | 1.02M | 248.21K | 142.94K | 61.27K | 18.97K | 7.20K | 0.00 | 0.00 | 0.00 |
| SG&A | 156.88M | 183.40M | 188.99M | 194.88M | 356.45M | 378.69M | 109.86M | 24.67M | 5.63M | 3.63M | 280.67K | 295.59K | 311.29K | 200.93K | 57.18K | 185.35K | 228.56K | 1.25K |
| Other Expenses | 1.67M | 0.00 | -21.59M | 6.13M | -28.64M | -3.26M | -907.00K | -1.14M | 593.22K | -5.06M | 25.82K | 107.29K | 19.50K | 409.00 | 583.00 | 834.00 | 490.00 | 0.00 |
| Operating Expenses | 158.54M | 189.96M | 240.60M | 225.09M | 450.93M | 456.84M | 123.63M | 25.70M | 6.79M | 4.37M | 306.49K | 402.88K | 330.79K | 201.33K | 57.77K | 186.18K | 229.05K | 1.25K |
| Cost & Expenses | 297.36M | 487.61M | 440.71M | 491.90M | 763.38M | 544.97M | 135.30M | 27.71M | 6.03M | 4.37M | 306.49K | 402.88K | 330.79K | 201.33K | 57.77K | 186.18K | 229.05K | 1.25K |
| Interest Income | 12.81M | 19.00M | 4.51M | 5.75M | 4.99M | 3.68M | 2.51M | 861.00K | 72.78K | 27.64K | 7.86K | 9.39K | 15.03K | 15.56K | 14.35K | 40.83K | 0.00 | 0.00 |
| Interest Expense | 14.19M | 39.46M | 71.81M | 66.44M | 77.54M | 41.03M | 2.28M | 1.29M | 619.12K | 177.41K | 101.08K | 9.39K | 15.03K | 745.00 | 484.00 | 310.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 33.07M | 43.57M | 93.66M | 98.08M | 114.89M | 88.26M | 12.26M | 1.09M | 593.22K | 304.80K | 303.00 | 432.00 | 422.00 | 409.00 | 583.00 | 834.00 | 490.00 | 0.00 |
| EBITDA | 20.47M | -210.74M | -143.09M | -137.20M | -393.23M | -214.66M | -78.46M | -12.98M | -4.75M | -9.24M | -298.33K | -402.45K | -330.36K | -185.36K | -57.18K | -144.52K | -228.56K | -1.25K |
| EBITDA Ratio | 7.58% | -90.34% | -64.65% | -55.94% | -140.99% | -86.58% | -142.14% | -71.86% | -329.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -353.91% | 0.00% | 0.00% |
| Operating Income | -46.45M | -254.32M | -231.45M | -282.82M | -490.96M | -314.24M | -95.77M | -11.19M | -4.59M | -4.37M | -306.49K | -402.88K | -330.79K | -202.08K | -58.25K | -145.35K | -229.05K | -1.25K |
| Operating Income Ratio | -17.19% | -109.01% | -104.57% | -115.32% | -176.03% | -126.74% | -173.51% | -61.95% | -318.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -355.95% | 0.00% | 0.00% |
| Total Other Income/Expenses | -31.15M | -41.10M | -1.43B | -392.46M | -2.83B | 6.14M | 168.08M | -1.90M | 89.08K | -5.06M | -93.22K | 9.39K | 15.03K | -167.26K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -59.60M | -295.42M | -1.72B | -699.80M | -3.38B | -328.23M | 77.33M | -17.26M | -5.87M | -9.73M | -399.71K | -393.49K | -315.76K | -353.77K | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -22.05% | -126.63% | -777.14% | -285.34% | -1,213.27% | -132.38% | 140.09% | -95.56% | -408.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -554.00K | -20.32M | -2.14M | -6.32M | -83.40M | -30.31M | 8.10M | -4.30M | -148.84K | -207.71K | 7.86K | 0.00 | 0.00 | -31.28K | -13.86K | 310.00 | -51.76K | -1.27K |
| Net Income | -69.33M | -265.33M | -1.72B | -693.63M | -3.31B | -290.84M | 71.94M | -12.97M | -5.72M | -9.52M | -399.71K | -393.49K | -315.76K | -322.50K | -43.91K | -145.66K | -177.29K | 1.27K |
| Net Income Ratio | -25.65% | -113.73% | -776.02% | -282.82% | -1,186.90% | -117.30% | 130.33% | -71.78% | -397.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -356.71% | 0.00% | 0.00% |
| EPS | -1.46 | -8.22 | -7.99 | -41.01 | -342.14 | -435.59 | 1.88 | -0.56 | -0.53 | -1.48 | -0.30 | -0.29 | -0.24 | -0.24 | -0.04 | -0.12 | -0.19 | 0.01 |
| EPS Diluted | -1.46 | -8.22 | -7.99 | -41.01 | -342.14 | -435.59 | 1.83 | -0.56 | -0.53 | -1.48 | -0.30 | -0.29 | -0.24 | -0.24 | -0.04 | -0.12 | -0.19 | 0.01 |
| Weighted Avg Shares Out | 47.42M | 32.27M | 214.91M | 16.91M | 9.68M | 667.69K | 38.32M | 23.25M | 10.75M | 6.41M | 1.35M | 1.34M | 1.32M | 1.32M | 1.23M | 1.20M | 935.16K | 162.85K |
| Weighted Avg Shares Out (Dil) | 47.42M | 32.27M | 214.91M | 16.91M | 9.68M | 667.69K | 39.28M | 23.25M | 10.75M | 6.41M | 1.35M | 1.34M | 1.32M | 1.32M | 1.23M | 1.20M | 935.16K | 162.85K |
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time highs of 2021.
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB , Nov. 26, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces developments...
Aurora Cannabis Expands Innovative Recreational Product Portfolio
NASDAQ | TSX: ACB Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands EDMONTON, AB , Nov. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is...
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pressures, but has significant upside potential with strategic buyers potentially paying mid-...
3 Marijuana Stocks For Today Watchlist
The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannabis politics surrounding reform and regulatory issues....
Aurora Cannabis: Buy The Election Overreaction
Aurora Cannabis dropped over 10%, along with the broader cannabis market, due to concerns over U.S. election results. Despite this, Aurora has no U.S. cannabis operations and is unaffected. Aurora reported robust revenue growth, with a 29% YoY increase, driven...
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
Aurora Cannabis Inc. (ACB) Beats Q2 Earnings and Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share. This compares to loss of $0.50 per share a year ago.
Cannabis stocks tank as Florida votes against recreational marijuana
Shares in cannabis stocks such as Trulieve Cannabis Corp. (CSE:TRUL), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) and Verano Holdings Corp (CSE:VRNO, OTCQX:VRNOF) tanked after Florida rejected legalization of recreational marijuana. A ballot measure, known as Amendment 3, which would have allowed adults to possess up...
Aurora Cannabis Inc. (ACB) Q2 2025 Earnings Call Transcript
Aurora Cannabis Inc. (NASDAQ:ACB ) Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants Kevin Niland - Director, Strategic Finance and IR Miguel Martin - CEO Simona King - CFO Conference Call Participants Frederico Gomes -...
Source: https://incomestatements.info
Category: Stock Reports